Skip to main content
Premium Trial:

Request an Annual Quote

Elsevier Buys Ariadne Genomics

NEW YORK (GenomeWeb News) – Scientific publishing firm Elsevier today announced it is buying the assets of genomics analysis firm Ariadne Genomics for an undisclosed amount.

Headquartered in Rockville, Md., Ariadne's flagship product is Pathway Studio for the analyses of molecular pathways and disease progression. The software suite comprises an integrated data mining and visualization product "that organizes relevant facts and relationships from large document collections of genes, proteins, cell processes, and diseases," Elsevier said in a statement.

Pathway Studio enables visualization of biological relationships spanning biomedical literature and helps researchers interpret experimental results using domain-specific ontologies, taxonomies, and dictionaries.

Ariadne will be integrated with Elsevier's Corporate Markets division.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.